690 related articles for article (PubMed ID: 17547042)
1. Chemoprophylaxis according to the guidelines on malaria prevention for Japanese overseas travelers.
Mizuno Y; Kudo K; Kano S
Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():11-4. PubMed ID: 17547042
[TBL] [Abstract][Full Text] [Related]
2. Knowledge, attitudes, and practices of Japanese travelers towards malaria prevention during overseas travel.
Namikawa K; Kikuchi H; Kato S; Takizawa Y; Konta A; Iida T; Kimura M
Travel Med Infect Dis; 2008 May; 6(3):137-41. PubMed ID: 18486069
[TBL] [Abstract][Full Text] [Related]
3. Malaria prevention and stand-by emergency treatment among Japanese travelers.
Kimura M; Kawakami K; Hashimoto M; Hamada M
Travel Med Infect Dis; 2006 Mar; 4(2):81-5. PubMed ID: 16887729
[TBL] [Abstract][Full Text] [Related]
4. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
Senn N; D'Acremont V; Landry P; Genton B
Am J Trop Med Hyg; 2007 Dec; 77(6):1010-4. PubMed ID: 18165513
[TBL] [Abstract][Full Text] [Related]
5. Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand.
Ropers G; Du Ry van Beest Holle M; Wichmann O; Kappelmayer L; Stüben U; Schönfeld C; Stark K
J Travel Med; 2008; 15(3):162-71. PubMed ID: 18494693
[TBL] [Abstract][Full Text] [Related]
6. Malaria chemoprophylaxis advice: survey of South African community pharmacists' knowledge and practices.
Toovey S
J Travel Med; 2006; 13(3):161-5. PubMed ID: 16706947
[TBL] [Abstract][Full Text] [Related]
7. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
[TBL] [Abstract][Full Text] [Related]
8. Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population.
Matsumura T; Fujii T; Miura T; Koibuchi T; Endo T; Nakamura H; Odawara T; Iwamoto A; Nakamura T
J Infect Chemother; 2005 Aug; 11(4):196-8. PubMed ID: 16133712
[TBL] [Abstract][Full Text] [Related]
9. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y
J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189
[TBL] [Abstract][Full Text] [Related]
10. Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention.
Lopez-Velez R; Bayas JM
J Travel Med; 2007; 14(5):297-305. PubMed ID: 17883460
[TBL] [Abstract][Full Text] [Related]
11. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
van Genderen PJ; Koene HR; Spong K; Overbosch D
J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478
[TBL] [Abstract][Full Text] [Related]
12. Inadequate chemoprophylaxis and the risk of malaria.
Massey P; Durrheim DN; Speare R
Aust Fam Physician; 2007 Dec; 36(12):1058-60. PubMed ID: 18075636
[TBL] [Abstract][Full Text] [Related]
13. Controversies and misconceptions in malaria chemoprophylaxis for travelers.
Chen LH; Wilson ME; Schlagenhauf P
JAMA; 2007 May; 297(20):2251-63. PubMed ID: 17519415
[TBL] [Abstract][Full Text] [Related]
14. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists].
Carme B; Péguet C; Nevez G
Bull Soc Pathol Exot; 1997; 90(4):273-6. PubMed ID: 9479468
[TBL] [Abstract][Full Text] [Related]
15. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
Wolters BA; Bosje T; Luinstra-Passchier MJ
Ned Tijdschr Geneeskd; 1997 Feb; 141(7):331-4. PubMed ID: 9132607
[TBL] [Abstract][Full Text] [Related]
16. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
Schwartz E; Regev-Yochay G
Clin Infect Dis; 1999 Dec; 29(6):1502-6. PubMed ID: 10585803
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice. Malaria prevention in short-term travelers.
Freedman DO
N Engl J Med; 2008 Aug; 359(6):603-12. PubMed ID: 18687641
[No Abstract] [Full Text] [Related]
18. Plasmodium falciparum malaria associated with mefloquine failure in Gambia.
Callen EC; Church CO
Pharmacotherapy; 2006 Oct; 26(10):1526-8. PubMed ID: 16999663
[TBL] [Abstract][Full Text] [Related]
19. Travel-related health problems in Japanese travelers.
Mizuno Y; Kudo K
Travel Med Infect Dis; 2009 Sep; 7(5):296-300. PubMed ID: 19747665
[TBL] [Abstract][Full Text] [Related]
20. Mefloquine for preventing malaria in nonimmune adult travelers.
Cayley WE
Am Fam Physician; 2004 Feb; 69(3):521-2. PubMed ID: 14971832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
